SPONSORED CONTENT
TIP: Covered entities must protect their 340B programs from manufacturers attempting to reduce savings and eligibility.
Blog Posts
A new federal regulation updating the definition of a covered outpatient drug could change the number of drugs covered under [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law
Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators issued final guidance for the next round of Medicare drug price negotiations yesterday but did not propose remedies [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Please join on us October 8th at 2pm EST for our second installment of RxParadigm’s 340B Clearinghouse Webinar Series.
As the 340B landscape continues to shift, it is time for action to deliver consistency and sustainability and a 340B future that
…
A key federal court decision to uphold Louisiana’s contact pharmacy law this week is drawing praise from provider groups and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...] …